European triathletes dominate Ironman races with the fastest times on Europe’s flat, fast courses, outpacing American participants despite their larger numbers.
Galapagos seeks ‘strategic options’ for Jyseleca as JAK inhibitor sales disappoint again
Galapagos is assessing “various strategic options” with Jyseleca, the JAK inhibitor that once inspired blockbuster projections but repeatedly disappointed. The Belgian biotech attributed the move